Olevsky, Olga M <br/><br/>
Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women.  [electronic resource] 

 -  Menopause (New York, N.Y.)   
 - 790-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1530-0374 
<br/><br/><label>Standard No.: </label>10.1097/gme.0b013e31817e6683  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bone Density Conservation Agents--administration & dosage<br/>Breast Neoplasms--prevention & control<br/>Female<br/>Humans<br/>Middle Aged<br/>Osteoporosis--drug therapy<br/>Postmenopause<br/>Raloxifene Hydrochloride--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Risk Factors<br/>Treatment Outcome